Drugmakers are growing frustrated with the National Health Service after a clawback tax unexpectedly soared, with ...

We recently compiled a list of the Billionaire Larry Robbins’ Long-Term Stock Picks. In this article, we are going to take a ...

The Trump administration is bringing new instability to a sector already grappling with a shaky market as well as threats ...

Ken Hall looks at three important considerations for investors looking to build a sizeable passive income for a better financial future.

The scrubbing of clinical trial-related pages is notable because of how it could affect the ways researchers both inside and ...

The pipeline will run for about 213 kilometres to a $7.4 billion polyethylene plant where construction started last September ...

BV100 is a new formulation of rifabutin suitable for intravenous administration, which BioVersys claims offers a new ...

Tata AIG has appointed Shekhar Saurabh as its Head of Marketing. The news has been shared by Saurabh in a LinkedIn update.

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

In pancreatic cancer, pelareorep previously demonstrated a strong efficacy signal when administered with gemcitabine, nab-paclitaxel and atezolizumab. Our new safety data indicate its ability to also ...

At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...

Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA ...